California Business Journal 
California Business Journal
What Foreign Manufacturers Should Know Before Choosing a U.S. FDA Agent

What Foreign Manufacturers Should Know Before Choosing a U.S. FDA Agent

For foreign companies selling food, cosmetics, medical devices, or pharmaceuticals in the United States, one of the first regulatory requirements they encounter is the need to designate a U.S. FDA Agent. It is a mandatory appointment under federal law, it…

By Roberta Silverglate, California Business Journal

Share on:

For foreign companies selling food, cosmetics, medical devices, or pharmaceuticals in the United States, one of the first regulatory requirements they encounter is the need to designate a U.S. FDA Agent. It is a mandatory appointment under federal law, it carries real compliance consequences if handled poorly, and yet many companies select an agent based on price alone without understanding what they are actually buying.

The decision deserves more deliberation than it typically receives.

What the Requirement Actually Is

The FDA requires every foreign facility registering with the agency to designate a U.S.-based agent. The legal basis sits in 21 CFR Part 207 for drug establishments and parallel provisions for food, device, and cosmetic registrations. The agent must be physically located in the United States, reachable by phone during regular business hours, and capable of receiving and transmitting official FDA communications on behalf of the foreign facility.

When the FDA has a compliance question, schedules an inspection, or needs to relay a document, that communication runs through the U.S. agent. A non-responsive or unqualified agent does not just create an administrative inconvenience. It creates a communication gap with a federal regulator that can delay or derail a company's U.S. market access.

Where Companies Tend to Go Wrong

The U.S. FDA agent services market includes providers ranging from large compliance firms with broad service portfolios to small specialty providers focused exclusively on registration and agent services. The variation in quality, responsiveness, and scope is significant.

Large compliance firms often carry strong brand recognition and wide service menus, but foreign manufacturers sometimes find themselves managed by rotating staff, working through ticketing systems, or paying for services they do not need in order to access the ones they do. Smaller, specialized providers can offer more direct access and competitive pricing, but vary considerably in experience level and infrastructure.

The practical questions worth asking before selecting a provider include: Who specifically will serve as the agent and be reachable when the FDA calls? What is the turnaround time for responding to FDA inquiries? Does the provider have experience with the specific product category involved? And what does the service actually cost on a per-year basis with no bundled obligations?

What Pricing Actually Looks Like

U.S. FDA agent services for foreign facilities typically range from roughly $269 to $299 per year for straightforward annual agent appointments, depending on the provider and whether a multi-year agreement is in place. Registration services, renewal management, and additional compliance work are generally priced separately.

Companies that bundle their agent appointment with their registration filing and renewal management under one provider tend to experience fewer errors and missed deadlines than those who split responsibilities across multiple parties. The coordination risk of having a separate agent, a separate registration filer, and an internal compliance contact is underestimated until something goes wrong.

The Renewal Factor

One of the most common and costly mistakes foreign manufacturers make is treating FDA registration as a one-time event. Food facility registrations require biennial renewal between October 1 and December 31 of even-numbered years. Medical device and drug establishment registrations renew annually during the same window. A missed renewal can result in an import refusal at the U.S. border, with shipments already in transit turned away on arrival.

A qualified U.S. FDA agent should be tracking renewal deadlines proactively, not waiting for the client to ask. This is one of the clearest ways to evaluate a provider before committing: ask directly how they manage renewal notifications and what their process is if a client's renewal window is approaching.

A San Diego-Based Option Worth Considering

For foreign manufacturers looking for a specialized provider with a direct service model, FDA Agent Pro is a San Diego-based firm with over 15 years of experience serving pharmaceutical, food and beverage, medical device, and cosmetic companies across more than 45 countries. Their focus is narrow by design: FDA agent services, registration, renewal, FSVP representation, and export certificates. No software subscriptions, no bundled training products, no upsells into services outside their lane.

For foreign companies that want a U.S. agent who answers the phone and knows their file, that kind of focused service model is worth evaluating alongside the larger names in the space.

The Bottom Line for Business Leaders

The U.S. FDA agent requirement is not optional, and the quality of the appointment has direct consequences for how smoothly a company operates in the U.S. market. Selecting a provider based on lowest cost or biggest name without evaluating responsiveness, experience, and renewal management practices is a risk that shows up later in the form of compliance gaps, communication delays, and in the worst cases, interrupted market access.

The companies that get this right treat the U.S. agent appointment as a vendor relationship that deserves the same due diligence as any other critical business partnership.

Copyright © 2026 California Business Journal. All Rights Reserved.

For California Business Journal Disclaimers, go to /terms-conditions/.

Advertisement

Advertisement: Ruth's Chris Steak House